Lexeo Therapeutics, Inc. $LXEO Shares Sold by Janus Henderson Group PLC
Janus Henderson Group PLC reduced its stake in Lexeo Therapeutics (NASDAQ:LXEO) by 9.7% in the first quarter, selling over 533,000 shares but still retaining a significant holding. Meanwhile, other institutional investors like Affinity Asset Advisors and Orbimed Advisors increased their positions in the clinical-stage …